2014/2562(DEA)

Situations in which post-authorisation efficacy studies may be required

Basic information

2014/2562(DEA)

DEA - Delegated acts procedure

Supplementing 2001/0252(COD)

Subject

4.20.04 Pharmaceutical products and industry

Status

Procedure completed - delegated act enters into force

Key players

  • European Parliament
    Committee responsible Rapporteur Appointed
    ENVI
    Environment, Public Health and Food Safety

Key events

Date Event Reference Summary
03/02/2014 Non-legislative basic document published C(2014)00432
03/02/2014 Initial period for examining delegated act 2.0 month(s)
05/02/2014 Committee referral announced in Parliament
15/04/2014 Delegated act not objected by Parliament

Technical information

Procedure Information
Procedure reference 2014/2562(DEA)
Procedure type DEA - Delegated acts procedure
Nature of procedure Examination of delegated act
Supplementing 2001/0252(COD)
Stage reached in procedure Procedure completed - delegated act enters into force
Committee dossier ENVI/7/15178

Documentation gateway

  • Document type Reference Date Summary
    Non-legislative basic document C(2014)00432 03/02/2014